InvestorsHub Logo
Followers 140
Posts 11663
Boards Moderated 0
Alias Born 03/15/2011

Re: corporalagarn post# 200160

Thursday, 12/18/2014 10:18:11 AM

Thursday, December 18, 2014 10:18:11 AM

Post# of 346050
corporal, personally I find they already DID better for PPHM then (only SOME of the BoD if not ONE in most cases) has done for the companies you cited.

Just look at what PPHM holds compared to what those mentioned companies ever were or are. PPHM is a 100+ employee company with 2 FDA PIII trial designs approved and a FULL pipeline. On top of that Avid that turns 20+Milj$ yearly with a gross profit of about 50% and extending (plus all PPHM clinical trial production of Bavituximab AT COST).

150+ clinical trial centers up and running. No creditors, owning 100% of IP and pipelines.

You know I can go on for ages with that list, so YES the one involved did DEFINITELY better for PPHM. Then of course King and Pohl were never involved in any of the mentioned companies and PPHM BoD/Management has a super team incl. Garnick, Brekken, Menander, Hutchking, Yopp, Freimark, Empig, and many others running their trials.

Peregrine Pharmaceuticals the Microsoft of Biotechnology! All In My Opinion. I am not advising anything, nor accusing anyone.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News